Die wichtigsten Publikationen
Muders MH. (2011) Neuropilin and Neuropilin Associated Molecules as New Molecular Targets in Pancreatic Adenocarcinoma. Anticancer Agents Med Chem. 11 (5): 442-447.
Rowley M, Ohashi A, Mondal G, Mills L, Yang L, Zhang L, Sundsbak R, Shapiro V, Muders MH, Smyrk T, Couch FJ.(2011) Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D dependent pancreatic cancer development in mice. Gastroenterology. 140(4):1303-1313.
Fu Z., Regan K., Zhang L., Muders MH, Thibodeau SN, French A, Wu Y, Kaufmann SH, Lingle WL, Chen J, Tindall DJ.(2009) Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibilty in mice. J Clin Invest. 119(9):2714-24.
Muders MH, Zhang H, Wang E, Tindall DJ, Datta K. (2009) Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and Akt-1. Cancer Res. 69(15):6042-48
Muders MH, Vohra PK, Dutta SK, Wang E, Ikeda Y, Wang L, Udugamasooriya DG, Memic A, Rupasinge CN, Baretton GB, Aust DE, Langer S, Datta K, Simons M, Spaller MR, Mukhopadhyay D (2009), Targeting GIPC/Synectin in pancreatic cancer inhibits tumor growth. Clin Cancer Res 15(12): 4095-103
Zhang H, Muders MH, Li J, Rindaldo F, Tindall DJ, Datta K (2008). Loss of NKX3.1 favors vascular endothelial growth factor-C expression in prostata cancer. Cancer Res. 68 (21):8770-8.
Rinaldo F, Li J, Wang E, Muders M, Datta K. (2007) RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation. Oncogene 26(12):1731-8.
Muders MH, Dutta SK, Wang L, Lau JS, Bhattacharya R, Smyrk TC, Chari ST, Datta K, Mukhopadhyay D. (2006) Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. Cancer Res 66(21): 10264-8.
Klicken Sie hier, um alle Publikationen in PubMed zu sehen.